The objectives of the present study were to evaluate in vitro the production of antagonistic compounds against Gardnerella vaginalis by Lactobacillus strains isolated from women with or without bacterial vaginosis (BV), and to select one of the better Lactobacillus producers of such a substance to be tested in vivo using a gnotobiotic animal model challenged with one of the more sensitive G. vaginalis isolates. A total of 24 isolates from women with and without BV were identified as G. vaginalis. A higher frequency (P,0.05) of this bacterium was observed in women with BV (56.7 %) when compared to healthy women (17.6 %). A total of 86 strains of Lactobacillus were obtained from healthy women and women with BV. Lactobacillus strains were more frequently present (P,0.05) in healthy women (97.5 %) than in women with BV (76.7 %). Lactobacillus crispatus was the predominating strain in both healthy women and women with BV. Lactobacillus jensenii, Lactobacillus johnsonii, Lactobacillus gasseri and Lactobacillus vaginalis were isolated with an intermediate frequency in the two groups. In vitro antagonism assays were performed using as indicators 17 reference strains and the G. vaginalis strains isolated from women with BV and from healthy women. Lactobacillus isolated from healthy women showed the higher antagonistic activity against all the indicator strains when compared with isolates from women with BV. Concerning the indicator strains, G. vaginalis found in women with BV was more resistant to the antagonism, particularly when Lactobacillus isolates from women with BV were used as producer strains. A high vaginal population level of G. vaginalis was obtained by intravaginal inoculation of germ-free mice, and this colonization was accompanied by vaginal histopathological lesions. A tenfold decrease in vaginal population level of G. vaginalis and a reduction of histological lesions were observed when the pathogenic challenge was performed in mice previously monoassociated with an L. johnsonii strain. Concluding, results of the present study suggest that progression of G. vaginalis-associated BV depends in part on a simultaneous presence of Lactobacillus populations with a low antagonistic capacity and of a G. vaginalis strain with a high resistance to this antagonism. The results could also explain why G. vaginalis is frequently found in the vaginal ecosystem of healthy women.
INTRODUCTION
Bacterial vaginosis (BV) is a polymicrobial syndrome where indigenous Lactobacillus populations, which are usually healthy women, but during BV their concentrations are generally increased 100-1000-fold over normal levels (Eschenbach, 2007) .
Factors that lead to the decline of the lactobacilli and the overgrowth of an atypical microbiota, as well as the sequence of bacterial population changes leading to BV, remain unknown. Microbial interactions, including synergism, commensalism and antagonism, can probably modify the environment so that it becomes adverse for some microorganisms by production of inhibitory compounds, but suitable for other organisms by releasing specific growth factors. Pybus & Onderdonk (1999) described in vitro nutritional inter-relationships that can explain commensalism between Prevotella bivia and both G. vaginalis and Peptostreptococcus anaerobius. However, production of antagonistic substances may also be an important factor in the competitive colonization of the vaginal ecosystem.
The lactobacilli metabolize glucose essentially into lactic acid, which contributes to the maintenance of a low vaginal pH (4.0-4.5) and reduces the growth of most pathogenic micro-organisms (Aroutcheva et al., 2001) . Many isolates of vaginal lactobacilli also produce H 2 O 2 , a compound having broad antimicrobial activity (Cherpes et al., 2008) . Among other antagonistic mechanisms, bacteriocinogenic activity is one of the most studied, and seems to contribute to the intraand inter-regulation of the human microbiota, influencing microbial invasion and defence (Riley & Wertz, 2002) .
G. vaginalis is a variable Gram-staining, facultatively anaerobic, non-motile, rod-shaped bacterium (Jarosik et al., 1998) , and is commonly found in the vaginal mucosa of asymptomatic women, but shows high concentrations in BV (Ingianni et al., 1997) . Recently, our laboratory reported the production of synergistic and/or antagonistic compounds by G. vaginalis (Teixeira et al., 2010) . In a second study, we confirmed the importance of high population levels of Lactobacillus (essentially Lactobacillus crispatus) and the quality of these lactobacilli as producers of antagonistic substances for a healthy vaginal environment (Branco et al., 2010) . These results showed that the quantity of beneficial bacteria as well as their qualities as producers of antagonistic compounds seem to be pivotal factors in understanding BV and the ecological role of these bacteria in the vaginal environment. However, these results were obtained in in vitro experiments, and it is not certain whether it occurs in vivo. The confirmation of the antagonistic phenomenon in an animal model could lead to the selection and development of probiotic Lactobacillus strains for the prevention and/or treatment of BV (Kaewsrichan et al., 2006) . The likely contribution of this mechanism is difficult to determine in the wider presence of a complex vaginal microbial ecosystem. For these reasons, the gnotobiotic mouse provides an in vivo simplified system that allows the observation of ecological interactions in the vaginal tissue among few microbial strains inoculated in this ecosystem.
The objectives of the present study were to evaluate in vitro the production of antagonistic compounds against G. vaginalis by Lactobacillus strains isolated from women with or without BV, and to select one of the best Lactobacillus producers of such a substance to be tested in vivo using a gnotobiotic animal model challenged with one of the most sensitive G. vaginalis isolates.
METHODS
Ethical aspects. This project was approved by the Ethics Committee of the Federal University of Minas Gerais for the experiments with humans (COEP, protocol 062/03) and written informed consent was obtained from all subjects before inclusion in the study. The study was also approved by the Ethics Committee in Animal Experimentation of the Federal University of Minas Gerais (CETEA/UFMG, protocol no. 227/2009).
Patients. The bacterial samples were isolated from healthy women (n540) and patients with BV (n530). Patients were screened at the Serviço de Ginecologia, Hospital das Clínicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Bacterial vaginosis was diagnosed when three out of four Amsel criteria were observed (Amsel et al., 1983) . Inclusion criteria were: women 18-45 years old, eumenorrheic, with normal blood glucose levels and with or without BV. The use of oral or topical antimicrobials 30 days before the sampling, pregnancy, menstruation, virginity and women in the puerperal phase or under immunosuppressive therapy were considered as exclusion criteria.
Vaginal sampling and sample processing. Vaginal samples were obtained using two 10 ml sterile loops which, after sampling, were introduced under a CO 2 flux in a tube containing 1 ml Ringer-PRAS solution and in a tube containing 1 ml Gardnerella transport medium, respectively. The samples were processed in a time range from 2 to 4 h after collection. The samples were introduced into an anaerobic chamber (Forma Scientific) containing an atmosphere of 85 % N 2 , 10 % H 2 and 5 % CO 2 , and submitted to serial decimal dilutions until 10 26 . Aliquots of 0.1 ml from dilutions were spread onto Vaginalis agar (using Columbia agar as base; Difco) and de Man, Rogosa and Sharp agar (MRS; Merck). After 48 h to 7 days of incubation at 37 uC, bacterial counts were determined and expressed as log 10 [c.f.u. (ml vaginal fluid) 21 ]. Colonies with distinct morphology were isolated on the respective medium. The bacterial samples were maintained at 280 uC in medium supplemented with 10 % glycerol.
Animals. Germ-free 28-day-old female mice (NIH, Taconic, Germantown, USA) were used in this study. The animals were housed in flexible plastic isolators (Standard Safety Equipment) and handled according to established procedures. Experiments with gnotobiotic mice were carried out in micro-isolators (UNO Roestvaststaal). Water and commercial autoclavable diet (Nuvital) were sterilized by steam and administered ad libitum, and animals were maintained in an animal house with controlled lighting (12 h light, 12 h dark). All experimental procedures were carried out according to the standards set forth in the 'Colegio Brasileiro de Experimentação Animal' rules (COBEA, 2006) .
G. vaginalis isolates. The isolates from Vaginalis agar were identified as G. vaginalis according to Piot et al. (1982) , using the results from Gram stain, catalase and oxidase tests, starch and hippurate hydrolysis, and a-and b-galactosidase activity. Activity of fructose-6-phosphate phosphoketolase was also evaluated (Orban & Patterson, 2000) .
Lactobacillus isolates. Bacteria isolated from the subjects were selected as presumptive Lactobacillus based on the following IP: 54.70.40.11
On: Thu, 07 Feb 2019 20:04:37 characteristics: Gram-positive, microaerophilic and catalase-negative rods isolated on MRS agar (Merck) at 37 uC. The selected strains were identified by amplified rDNA restriction analysis as described by Moreira et al. (2005) .
DNA extraction. Chromosomal DNA was isolated from overnight cultures of all isolates in 10 ml MRS broth. After washing the cells with deionized water, the pellet was obtained by centrifugation at 14 000 g for 5 min at 4 uC, suspended in 1 ml 5 M LiCl, and incubated for 1 h with constant shaking. After a second washing with 1 ml deionized water, the pellet was suspended in 1 ml protoplasting buffer (50 mM Tris/HCl, pH 8.0; 10 mM EDTA; 10 mg lysozyme ml 21 ; 100 mg RNase ml 21 ). After incubation for 1 h at 37 uC and centrifugation at 14 000 g for 5 min at 4 uC, the pellet was suspended in 500 ml protoplasting buffer without lysozyme, and 100 ml 10 % SDS was added to allow cells to lyse. After lysis, the mixture was extracted once with phenol, phenol-chloroform-isoamyl alcohol (25 : 24 : 1) and chloroform-isoamyl alcohol (24 : 1). After 2-propanol precipitation, the DNA was dissolved in 100 ml TE buffer (10 mM Tris/HCl, 1 mM EDTA, pH 8.0).
PCR amplification of the 16S-23S rRNA gene intergenic
spacer. The 16S-23S rRNA gene intergenic spacer region was amplified using the primer 16-1A (GAATCGCTAGTAATCG), which anneals to a conserved region of the 16S rRNA genes, and primer 23-1B (GGGTTCCCCCATTCGGA), which anneals to a conserved region of the 23S rRNA genes, using a PTC-100 Thermal cycler (MJ Research). The reaction mixture (50 ml) contained 10 pM of each primer, 0.2 mM of each deoxyribonucleotide triphosphate, reaction buffer containing 1.5 mM MgCl 2 , 5 U Taq DNA polymerase (Phoneutria Biotecnologia & Serviços) and 5 ml template DNA solution. The amplification program was 95 uC for 2 min, 35 cycles of 95 uC for 30 s, 55 uC for 1 min, 72 uC for 1 min, and finally 72 uC for 10 min. PCR products were electrophoresed on a 1.4 % agarose gel and visualized by UV transillumination after staining with an ethidium bromide solution (5 mg ml 21 ).
Amplified rDNA restriction analysis. The amplified 16S-23S rRNA intergenic spacer regions of lactic acid bacteria were digested with a set of 12 enzymes chosen after compilation of nucleotide sequences already deposited at GenBank and in silico restriction digestion using the Webcutter 2.0 tool (Heiman, 1997 ; http://rna.lundberg.gu.se/cutter2/). SphI, NcoI and NheI enzymes hydrolysed inside the 16S rRNA gene; SspI, SfuI, DraI, VspI, HincII and EcoRI enzymes hydrolysed inside the intergenic region; and AvrII and HindIII enzymes hydrolysed inside the 23S rRNA gene. EcoRV enzyme hydrolysed inside the spacer region for the Lactobacillus casei group and in the 23S rRNA gene for the Lactobacillus acidophilus group. For several lactobacillus species no spacer nucleotide sequences have been reported and only fragments of the 16S and/or 23S rRNA genes were found. All restriction enzymes were purchased from Promega.
In vitro antagonism assay. The isolated lactobacilli were cultured in MRS broth for 24 h at 37 uC in the anaerobic chamber (Forma Scientific). After growth, an aliquot (5 ml) of the culture was spotted onto MRS agar (Difco). After incubation at 37 uC for 48 h under anaerobic conditions, the cells were killed by exposure to chloroform for 20 min. Residual chloroform was allowed to evaporate and Petri dishes were overlaid with 3.5 ml brain heart infusion (BHI) or Sabouraud soft agar (0.7 %) (Difco), which had been inoculated with 0.2 ml of a 24 h culture of the indicator strain to be tested. All the G. vaginalis isolates from women with or without BV were used as indicator strains, as well as and Candida albicans ATCC 18804. After 24 h of incubation at 37 uC under aerobic or anaerobic conditions depending on the indicator strain, the antagonistic activity was determined as the presence of a growth inhibition zone around the spot.
Determination of H 2 O 2 production. To test for the production of H 2 O 2 by lactobacillus isolates, a qualitative assay on tetramethylbenzidine (TMB; Sigma) agar plates was done as described by Rabe & Hillier (2003) . Lactobacilli were inoculated onto TMB agar plates and incubated in the anaerobic chamber at 37 uC. After 40 h, the plates were exposed to ambient air. If the lactobacilli produced H 2 O 2 , a reaction occurred with horseradish peroxidase (Sigma) present in the medium, which oxidizes TMB, causing the colonies to turn blue. Lactobacillus acidophilus ATCC 4356 was used as a control.
In vivo antagonism assay. The Lactobacillus johnsonii strain used in this assay was selected based on its high antagonistic activity, and the G. vaginalis strain on its high sensitivity to this antagonism. In a first experiment, two groups of germ-free mice were submitted to the following protocols: group LJGV received by intravaginal inoculation a unique dose of 0.1 ml containing 9.0 log c.f.u. L. johnsonii ml 21 , and 10 days later the monoxenic animals were inoculated intravaginally with 0.1 ml of a suspension containing 7.0 log c.f.u. G. vaginalis ml 21 . The second group, GV, received only sterile saline by vaginal application 10 days before the pathogenic challenge. In a second experiment, two groups were submitted to the same protocols described above, but both were also injected subcutaneously with two doses of 0.5 ml oestradiol benzoate (0.5 mg in 0.1 ml peanut oil) 72 h before the challenge and 72 h after the challenge, respectively (LJGVH and GVH). One week after the challenge, all the mice were sacrificed by cervical dislocation and vaginal tissues were removed. In a third experiment, two groups were treated only with the lactobacillus, with or without the hormonal treatment, and were sacrificed 17 days after the monoassociation with the lactobacillus (LJ and LJH). Three germfree mice were used in each group.
Part of the tissue was weighed and suspended in a volume of sterile PBS to obtain, after homogenization, a dilution of 10 21 (w/v). Then, this suspension was introduced into the anaerobic chamber and submitted to serial decimal dilutions in PBS. A 0.1 ml aliquot of the dilutions was spread onto Vaginalis agar and/or MRS agar, and incubated for 48 h at 37 uC for bacterial count. All the determinations were performed in triplicate.
Another part of the vaginal tissue was fixed in buffered 4 % formaldehyde and processed for paraffin embedding. The histopathological sections (3-5 mm) were stained with haematoxylin and eosin (H&E). The slides were coded and examined by a single pathologist, who was unaware of the experimental conditions of each group.
Statistical analysis. Data were analysed using the Minitab Release 14.20 software. Fisher's exact test and Kruskal-Wallis one-way analysis of variance followed by pair-wise multiple comparisons using the Student-Newman-Keuls method were used. P,0.05 was considered to be statistically significant.
RESULTS
A total of 24 isolates from women with (17 isolates) and without (7 isolates) BV were identified as G. vaginalis. Table  1 shows a higher frequency (P,0.05) of this bacterium in women with BV (56.7 %) when compared to healthy women (17.6 %). However, when present, the vaginal population levels of G. vaginalis were similar in both groups, and reached about 8.0 log c.f.u. (ml vaginal fluid) 21 . A total of 86 strains of Lactobacillus were obtained from healthy women (58 isolates) and women with BV (28 isolates). Lactobacillus strains were more frequently present (P,0.05) in healthy women (97.5 %) than in women with BV (76.7 %), but as for G. vaginalis, vaginal population levels were similar in both groups and reached about 6.8 log c.f.u. (ml vaginal fluid) 21 . Lactobacillus crispatus was the predominating strain in both healthy women (22 isolates) and women with BV (7 isolates). Lactobacillus jensenii, L. johnsonii, Lactobacillus gasseri and Lactobacillus vaginalis were isolated with an intermediate frequency in the two groups.
A total of 2549 assays of antagonism were performed in the present study, using as indicators the reference strains and the G. vaginalis isolates from women with BV and from healthy women. The Lactobacillus isolates from healthy women showed a higher antagonistic activity against the indicator strains when compared with isolates from women with BV (Table 2) . Additionally, all the 24 G. vaginalis isolates used as indicator were sensitive to at least one of the Lactobacillus isolates from healthy women and tested in the antagonistic assay (data not shown). However, 64.7 % of the G. vaginalis isolated from patients with BV and 42.8 % of those from healthy women were resistant to all the 17 Lactobacillus isolates from women with BV (data not shown). Concerning the indicator strains, G. vaginalis found in women with BV was more resistant to the antagonism, particularly when Lactobacillus isolates from women with BV were used as producer strains. However, a statistical significance (P,0.05) was observed only when Lactobacillus species from healthy women were tested. The higher antagonistic activity frequency (of about 70 %) was observed when L. johnsonii isolates were assayed against G. vaginalis, both from healthy women. Table 3 shows that 57.4 % of the Lactobacillus isolates produced H 2 O 2 , with a slightly higher frequency (45.5 %) for strains isolated from healthy women than from women with BV (35.3 %). However, this difference was not statistically significant (P.0.05), but this can be due to the too low number of strains tested. L. johnsonii from healthy women was the highest producer of H 2 O 2 in terms of intensity of production.
For the in vivo study of the inter-relationships between Lactobacillus and G. vaginalis, a highly antagonistic and H 2 O 2 producer strain of L. johnsonii from a healthy woman was tested against a G. vaginalis isolate selected for its high sensitivity to this antagonism. Fig. 1(a) shows that treatment with oestradiol benzoate was necessary for the colonization of germ-free mice by L. johnsonii, but not for G. vaginalis (Fig. 1b) . When the colonization was obtained, ] was observed when the monoassociated mice were posteriorly challenged with G. vaginalis (Fig. 1c) . A tenfold reduction in vaginal population levels of G. vaginalis was observed when the pathogenic challenge was performed in mice previously monoassociated with L. johnsonii, and this reduction was statistically significant in the mice not treated with hormone (from 5.01 to 3.62 log c.f.u. g 21 ; P50.009). A tendency for a similar effect was also noted in animals treated with the hormone (from 4.40 to 3.34 log c.f.u. g 21 ; P50.078). Histological examination of the vaginal mucosa from germfree mice showed no inflammation or hyperaemia of the epithelium. In mice only monoassociated with L. johnsonii, a discrete inflammatory infiltrate was observed, as well as a direct transition from columnar to mature squamous epithelium. In mice challenged with G. vaginalis, histopathological examination showed inflammatory alterations of the ectocervix and lamina propria epithelium. In mice pre-treated with L. johnsonii before the challenge with G. vaginalis, the inflammatory infiltrate and oedema were less pronounced. In these mice, no differences were observed in relation to the germ-free animal for the endocervical epithelium aspects. Table 4 presents the results obtained from the histopathological examination and shows a clear 
DISCUSSION
The presence of a high population of Lactobacillus species is well known as an important factor for a healthy vaginal ecosystem (Hillier, 2005; Falagas et al., 2007) . However, beyond their high local levels, these lactobacilli must also be highly antagonistic against potential pathogenic microorganisms to offer protection. There is little information about the importance of the sensitivity of the pathogenic target to this antagonism. Additionally, the antagonistic property is generally demonstrated by in vitro assay, and it is not certain whether this ability can be extrapolated to in vivo conditions.
The present study confirms that Lactobacillus species are more frequently found in the vaginal ecosystem of healthy subjects than in patients with BV (Mikamo et al., 2000; Eschenbach, 2007; Klomp et al., 2008) . Moreover, as described in other studies (Hellberg et al., 2001; Branco et al., 2010; Srinivasan et al., 2010) , G. vaginalis frequency was higher in patients with BV when compared to healthy women. However, when present in patients with BV, Lactobacillus levels were similar to those found in healthy women, suggesting that a beneficial effect of these bacteria depends not only on their presence in high quantities but also on their quality in term of protective ability. These results were different from those in some studies which observed higher levels of Lactobacillus in healthy women (Mikamo et al., 2000; Eschenbach, 2007; Klomp et al., 2008) . Similarly, G. vaginalis population levels when present in healthy women were as high as in patients with BV, suggesting on the other hand that pathological symptoms of infection depend also on the pathogenic capacity of the bacteria and not only on their quantities.
Many studies have suggested that the presence of H 2 O 2producing vaginal lactobacilli may protect against BV, although some studies do not support this hypothesis (Falagas et al., 2007) . In the present study, L. johnsonii from healthy women showed better antagonistic properties and H 2 O 2 production when compared to the other Lactobacillus species. In fact, the production of lactic acid by lactobacilli, which is mainly responsible for the low vaginal pH, could contribute more than the production of H 2 O 2 to the inhibition of the G. vaginalis growth (McLean & McGroarty, 1996) . However, in the present study, experiments determining the most acidic culture supernatant after growth of the various Lactobacillus isolates have not been performed to correlate this information with their antagonistic abilities. The most interesting information described here is related to the need for a high Lactobacillus inhibitory capacity combined with a high G. vaginalis susceptibility to direct the vaginal ecosystem to a healthy status and inversely for the BV status.
No reports are available in the literature using animal models to confirm in vivo the antagonistic properties demonstrated in vitro for vaginal Lactobacillus against pathogens. For such finality, it is necessary to obtain animals which can be colonized by human lactobacilli and infected by human G. vaginalis. The progression of colonization/infection of body epithelial surfaces by a micro-organism depends mainly on its resistance to the local conditions (such as the mucosal barrier integrity, the indigenous microbiota balance and the immunological status of the host), its ability to use the available nutrients and its capacity to adhere to the mucosa. Few studies describe experimental vaginal inoculation of micro-organisms in animal models, and none of them used germ-free animals for such finality (Johnson et al., 1984; Fidel et al., 2000; de Ruiz et al., 2001; Hamad et al., 2004) . In these animal models, the authors recommended an oestrogen administration to induce a pre-oestral stage, which ensures a successful colonization/infection. In healthy human vaginas, it is well known that the presence and number of lactobacilli are influenced by oestrogen production (Keane et al., 1997) . Oestrogen converts columnar epithelium into a thick layer of squamous stratified epithelium and increases the glycogen content and other substrates for bacterial growth. As expected from this information, vaginal colonization of germ-free mice by the selected L. johnsonii strain was observed in the present study only in animals treated with the hormone. However, this treatment was not necessary for the G. vaginalis colonization. Interestingly, vaginal colonization by L. johnsonii was obtained without hormonal treatment when the mice were also challenged with G. vaginalis. However, the L. johnsonii population levels were higher in this diassociated model when the mice were treated with oestradiol when compared to the non-treated group. We have no strong explanation for this phenomenon, but the presence of G. vaginalis could provide a synergistic effect for the growth of L. johnsonii similar to that described for Peptostreptococcus anaerobius in a recent study in our laboratory (Teixeira et al., 2010) . In any case, the previous monoassociation with L. johnsonii protected the mice against the vaginal challenge with G. vaginalis as demonstrated by both lower population levels of the pathogen and the reduced lesions observed from the histopathological examination. However, it was not possible to determine in this animal model whether the protection was due to the production of antagonistic compounds observed in the in vitro assays or to other mechanisms such as co-aggregation or competition for shared adhesion receptors or nutrients between the lactobacillus and the pathogen.
Concluding, results of the present study suggest that the success of BV due to G. vaginalis depends, at least in part, on a simultaneous presence of Lactobacillus populations with low antagonistic capacity and of a G. vaginalis strain with a high resistance to this antagonism. 
